SUDEEPPHRM — Sudeep Pharma Balance Sheet
0.000.00%
- IN₹74.94bn
- IN₹75.79bn
- IN₹4.97bn
Annual balance sheet for Sudeep Pharma, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2022 March 31st | 2023 March 31st | 2024 March 31st | 2025 March 31st | |
|---|---|---|---|---|
| Period Length: | — | — | — | — |
| Source: | PROSPECTUS | PROSPECTUS | PROSPECTUS | ARS |
| Standards: | IAS | IAS | IAS | IAS |
| Status: | Final | Final | Final | Final |
| Cash | ||||
| Cash and Equivalents | ||||
| Short Term Investments | ||||
| Cash and Short Term Investments | 215 | 133 | 141 | 519 |
| Net Total Accounts Receivable | ||||
| Net Total Receivables | 1,188 | 1,268 | 1,690 | 2,178 |
| Total Inventory | ||||
| Prepaid Expenses | ||||
| Total Other Current Assets | ||||
| Total Current Assets | 1,962 | 2,300 | 2,754 | 4,241 |
| Gross Property, Plant And Equipment | ||||
| Accumulated Depreciation | ||||
| Net Property, Plant And Equipment | 1,459 | 1,838 | 2,246 | 2,773 |
| Net Intangible Assets | ||||
| Long Term Investments | ||||
| Long Term Notes Receivable | ||||
| Other Long Term Assets | ||||
| Total Assets | 3,450 | 4,201 | 5,139 | 7,172 |
| Accounts Payable | ||||
| Accrued Expenses | ||||
| Notes Payable / Short Term Debt | ||||
| Current Portion of Long Term Debt / Capital Leases | ||||
| Total Other Current Liabilities | ||||
| Total Current Liabilities | 1,475 | 1,708 | 1,373 | 1,748 |
| Long Term Debt | ||||
| Capital Lease Obligations | ||||
| Total Long Term Debt | ||||
| Total Debt | ||||
| Deferred Income Tax | ||||
| Total Other Liabilities | ||||
| Total Funded Status | ||||
| Total Liabilities | 1,822 | 1,968 | 1,579 | 2,241 |
| Common Stock | ||||
| Additional Paid In Capital | ||||
| Retained Earnings (Accumulated Deficit) | ||||
| Other Equity | ||||
| Total Equity | 1,628 | 2,233 | 3,560 | 4,931 |
| Total Liabilities & Shareholders' Equity | 3,450 | 4,201 | 5,139 | 7,172 |
| Total Common Shares Outstanding |